20403 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
Modulators of orphan nuclear receptors for NASH and other metabolic disorders
#302METHODS FOR TREATING CANCER AND PROTECTING RENEWABLE TISSUES
#303Cholecystokinin B receptor targeting for imaging and therapy
#304PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#305Car activator agents for cyclophosphamide-based treatments of cancer
#306METHODS AND COMPOSITIONS RELATING TO P62 FOR THE TREATMENT AND PROPHYLAXIS OF CANCER
#307FORMULATIONS, SYSTEMS, AND METHODS FOR THERAPEUTIC TREATMENT
#308ITE FOR CANCER INTERVENTION AND ERADICATION
#309Targeted Therapeutic Nanoparticles And Methods Of Making And Using Same
#310PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#311PSMA binding ligand-linker conjugates and methods for using
#312Apilimod compositions and methods for using same
#313Combination Therapy for Cancer Treatment
#314Inhibitors of hepatitis C virus replication
#315PSMA binding ligand-linker conjugates and methods for using
#316Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
#317Methods for solid tumor treatment
#318COMBINATION THERAPY USING A CD19-ADC AND RCHP
#319Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
#320MINIMALLY TOXIC PRODRUGS
#321Compositions and methods for treatment of erectile disfunction
#322PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#323Methods for solid tumor treatment
#324Methods for solid tumor treatment
#325Synchronizing Tumor Cells to the G2/M Phase Using TTFields Combined with Taxane or Other Anti-Microtubule Agents
#326Liposomes for drug delivery and methods for preparation thereof
#327Use of inhibitors of Bruton's tyrosine kinase (Btk)
#328PSMA binding ligand-linker conjugates and methods for using
#329PSMA binding ligand-linker conjugates and methods for using
#330ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER
#331Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
#332Folate receptor binding conjugates of antifolates
#333Compositions and methods for treatment of erectile dysfunction
#334Compositions and methods for treatment of erectile disfunction
#335Indole regulation of antigen presenting cells
#336SENOLYTIC COMPOUNDS
#337MODIFIED CYCLODEXTRIN COATED MAGNETITE NANOPARTICLES FOR TARGETED DELIVERY OF HYDROPHOBIC DRUGS
#338Allele specific modulators of P23H rhodopsin
#339Agents and methods for treating and preventing seborrheic keratosis
#340Compounds and methods for inhibiting phosphate transport
#341Combination of cannabinoids in the treatment of leukaemia
#342DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#343Compositions and methods for combination pharmacological treatments to induce a prolonged, mild decrease in core body temperature
#344Exosomal compositions and methods for the treatment of disease
#345Site-specific conjugation of linker drugs to antibodies and resulting ADCS
#346Site-specific conjugation of linker drugs to antibodies and resulting ADCS
#347Coated edible plant-derived microvesicle compositions and methods for using the same
#348Targeted polymerized nanoparticles for cancer treatment
#349INDOLIZINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#350Use of inhibitors of bruton's tyrosine kinase (BTK)
#351Combinations of a mithramycin analogue and another chemotherapeutic agent for the treatment of triple negative breast cancer
#352PROPHYLAXIS TREATMENT FOR ACUTE MYELOID LEUKEMIA
#353Methods for solid tumor treatment
#354Methods of inhibiting PCSK9
#355EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#3564-amino-2-pyrido-bicyclic pyrimidines and use thereof as topoisomerase II inhibitors
#357VINFLUNINE AND PD1 AND/OR PDL1 INHIBITOR AS PHARMACEUTICAL COMBINATION
#358METHODS OF TREATING NEUROBLASTOMA AND REAGENTS THEREFOR
#359Non-adult human dosing of brentuximab vedotin
#360Silicon based drug conjugates and methods of using same
#361Treatment of Hodgkin lymphoma using an anti-PD-1 antibody
#362COMBINATIONS FOR THE TREATMENT OF NEOPLASMS USING QUIESCENT CELL TARGETING AND INHIBITORS OF MITOSIS
#363ITE FOR CANCER INTERVENTION AND ERADICATION
#364Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof
#365Apparatus and method for the treatment of melanoma
#366EZH2 inhibitors for treating lymphoma
#367COMPOUND AND METHOD FOR REDUCING NEUROPATHIC PAIN AND DEPRESSION
#368ULTRASOUND TRIGGERED RELEASE FROM METAL ORGANIC FRAMEWORK NANOCARRIERS
#369Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
#370Anti-MERTK agonistic antibodies and uses thereof
#371Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
#372Controlled drug release liposome compositions and methods thereof
#373COMPOSITIONS FOR AND METHODS OF TREATING AND PREVENTING CANCER TARGETING TUMOR ASSOCIATED CARBOHYDRATE ANTIGENS
#374Systems and methods for cardiac plexus neuromodulation
#375Combination therapies using HDAC inhibitors
#376Pyrvinium pamoate therapies and methods of use
#377Small molecule prolactin receptor inhibitors, pharmaceutical compositions and treatment methods using such inhibitors
#378Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
#3791,4-dihydropyridine derivatives with HSP modulating activity
#380METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#381Apilimod Compositions and Methods for Using Same
#382Anti-fibulin-3 antibodies and uses thereof
#383Minimally toxic prodrugs
#384METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES
#385MEBENDAZOLE CANCER THERAPIES AND METHODS OF USE
#386Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
#387Cell therapy compositions and methods of use thereof
#388Targeted Therapeutic Nanoparticles And Methods Of Making And Using Same
#389Fucoidan nanogels and methods of their use and manufacture
#390Methods of cancer treatment with 2-(1′H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester
#391INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#392Predictive clinical assays and methods of using same
#393COMBINATION THERAPY COMPOSITIONS AND METHODS FOR TREATING CANCERS
#394Indole derivatives for use in medicine
#395Combinations of LSD1 inhibitors for the treatment of hematological malignancies
#396Cholecystokinin B receptor targeting for imaging and therapy
#397Vaporized medicants and methods of use
#398USING MICROBIOTA METABOLITES TO DIFFERENTIATE NAÏVE T-CELLS AND RELATED METHODS TO INDUCE OR PREVENT INFLAMMATORY CONDITIONS
#399Methods for solid tumor treatment
#400ELP fusion proteins for controlled and sustained release
#401Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
#402Dosage form of vinca alkaloid drug
#403PSMA binding ligand-linker conjugates and methods for using
#404Compositions for delivery of drug combinations
#405COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY
#406Agents and methods for treating and preventing seborrheic keratosis
#407Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
#408PSMA binding ligand-linker conjugates and methods for using
#409AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY
#410PSMA binding ligand-linker conjugates and methods for using
#411PSMA binding ligand-linker conjugates and methods for using
#412PSMA binding ligand-linker conjugates and methods for using
#413EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
#414Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors
#415Oligonucleotides for modulating gene expression and uses thereof
#416USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#417SYK INHIBITORS
#418PSMA binding ligand-linker conjugates and methods for using
#419PSMA binding ligand-linker conjugates and methods for using
#420PSMA binding ligand-linker conjugates and methods for using
#421Histone Deacetylase (hdac) Inhibitors For The Treatment Of Cancer
#422Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones
#423Use of inhibitors of bruton's tyrosine kinase (Btk)
#424Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds
#425PSMA binding ligand-linker conjugates and methods for using
#426LIPOSOMES USEFUL FOR DRUG DELIVERY
#427NORADRENERGIC DRUG TREATMENT OF OBSTRUCTIVE SLEEP APNEA
#428Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#429DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#430POTENTIATION OF ANTICANCER AGENTS
#431Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
#432Methods for treating chemoresistant cancer-initiating cells
#433EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#434Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
#435Allele specific modulators of P23H rhodopsin
#436Liposomes useful for drug delivery
#437Vaporized medicants and methods of use
#438Ready-to-use formulation for Vincristine Sulfate Liposome Injection
#439SYSTEMS AND METHODS FOR SYMPATHETIC CARDIOPULMONARY NEUROMODULATION
#440COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL AND DIACETYLDIANHYDROGALACTITOL
#441METHOD FOR ISOLATION OF ALKALOIDS AND AMINO ACIDS, AND COMPOSITIONS CONTAINING ISOLATED ALKALOIDS AND AMINO ACIDS
#442Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
#443Combination therapy for cancer treatment
#444Anthracycline prodrugs and methods of making and using the same
#445ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
#446Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
#447NANOPORPHYRIN TELODENDRIMERS FOR TREATMENT OF VASCULAR ABNORMALITIES
#448Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
#449Pharmaceutical Oral Dose Formulation and Composition of Matter
#450METHODS OF TREATING CANCER USING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE
#451Pharmaceutical oral dose formulation and composition of matter
#452Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations
#453NOVEL COMPOSITIONS OF COMBINATIONS OF NON-COVALENT DNA BINDING AGENTS AND ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS AND THEIR USE IN DISEASE TREATMENT
#454Use of inhibitors of Bruton's tyrosine kinase (Btk)
#455COMBINATION THERAPY USING A CD19-ADC AND VINCRISTINE
#456BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#457Use of inhibitors of Bruton's tyrosine kinase (Btk)
#458Furoquinolinediones as inhibitors of TDP2
#459Synchronizing Tumor Cells to the G2/M Phase Using TTFields Combined with Taxane or Other Anti-Microtubule Agents
#460Combination methods for treating cancers
#461Modified cyclodextrin coated magnetite nanoparticles for targeted delivery of hydrophobic drugs
#462Anti-MERTK agonistic antibodies and uses thereof
#463FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES
#464METHODS OF TREATING UROTHELIAL CARCINOMA
#465Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds
#466Liposomes useful for drug delivery
#467Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#468Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair
#469ITE for cancer intervention and eradication
#470Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
#471Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist
#472Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis
#473Combinations of LSD1 inhibitors for use in the treatment of solid tumors
#474Regulation of autonomic control of bladder voiding after a complete spinal cord injury
#475Therapeutic and research application of PDCL3
#476COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS
#477Small molecule conjugates specifically activated in tumor microenvironment for targeting and use thereof
#478Controlled drug release liposome compositions and methods thereof
#479USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#480PSMA binding ligand-linker conjugates and methods for using
#481Micelle containing epirubicin-complexed block copolymer and anti-cancer agent, and pharmaceutical composition containing said micelle applicable to treatment of cancer, resistant cancer or metastatic cancer
#482Solubility of therapeutic agents
#483Block copolymers for stable micelles
#484USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION
#485Folate receptor binding conjugates of antifolates
#486Block copolymers for stable micelles
#487Antineoplastic combinations containing HKI-272 and vinorelbine
#488Development of neurokinin-1 receptor-binding agent delivery conjugates
#489Classifiers of NF-κB pathway activation, devices, and methods of use thereof
#490Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer
#491Silicon based drug conjugates and methods of using same
#492FORMULATION FOR INCREASING ENERGY
#493Combination therapies with anti-CD38 antibodies
#494Histone deacetylase (HDAC) inhibitors for the treatment of cancer
#495Liposomes with ginsenoside as membrane material and preparations and use thereof
#496Method of treating cancer
#497Small molecules targeting repeat r(CGG) sequences
#498Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
#499Nutritional supplements affecting mood state
#500Targeted therapeutic nanoparticles and methods of making and using same
#501PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#502ENERGY COMPOSITION
#503Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
#504Indole derivatives for use in medicine
#505COMPOSITIONS CONTAINING NITRIC OXIDE AMINO ACID ESTERS AND METHODS FOR IMPROVING SEXUAL PERFORMANCE
#506Human-mouse chimeric anti-CD147 antibody with non-fucosylated glycosylation
#507Compositions, packaged pharmaceuticals, and methods of using hedgehog pathway modulators for the sensitization of resistant tumors
#508Site-specific conjugation of linker drugs to antibodies and resulting ADCs
#509Liposomes useful for drug delivery
#510COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY
#511Compositions and methods for drug-sensitization or inhibition of a cancer cell
#512Liposomes useful for drug delivery
#513SMALL ncRNAS AS BIOMARKERS
#514Combination therapy for cancer treatment
#515Methods and compositions relating to P62 for the treatment and prophylaxis of cancer
#516Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
#517Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
#518Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#519TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA WITH ANTI-CD20 ANTIBODY
#520Use of inhibitors of Bruton'S tyrosine kinase (Btk)
#521Syk inhibitors
#522CLASSIFICATION OF MYC-DRIVEN B-CELL LYMPHOMAS
#523Compositions and methods for combination pharmacological treatments to induce a prolonged, mild decrease in core body temperature
#524Targeted polymerized nanoparticles for cancer treatment
#525Anti-fibulin-3 antibodies and uses thereof
#526SOCS mimetics for the treatment of diseases
#527Energy Composition
#528Apilimod compositions and methods for using same
#529Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
#530Herbal combinations for treating eczema
#531Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
#532Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#533DRUG LOADED POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME
#534Liposomes Useful for Drug Delivery
#535Therapeutic Polymeric Nanoparticles Comprising Vinca Alkaloids and Methods of Making and Using Same
#536Drug loaded polymeric nanoparticles and methods of making and using same
#537Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
#538Use of inhibitors of bruton's tyrosine kinase (BTK)
#539Systems and methods for sympathetic cardiopulmonary neuromodulation
#540Pharmaceutical composition for treatment of radiation- or drug-resistant cancer comprising HRP-3 inhibitor
#541COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES INVOLVING HIPPO PATHWAY
#542Block copolymers for stable micelles
#543Folate receptor binding conjugates of antifolates
#544Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
#545Identification of structurally similar small molecules that enhance therapeutic exon skipping
#546In vivo individualized systemic immunotherapeutic method and device
#547Combined application of isothiocyanate compound and anti-cancer medicine
#548Methods of increasing the cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-Lys, polyamine acetylation, and polyamine metabolism
#549LIGAND-THERAPEUTIC AGENT CONJUGATES, SILICON-BASED LINKERS, AND METHODS FOR MAKING AND USING THEM
#550Identification of small molecules that facilitate therapeutic exon skipping
#551COMPOSITIONS AND METHODS USING ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA
#552Compositions and methods for enhancing brain function
#553Inhibition of thymine DNA glycosylase in the treatment of cancer
#554Lipophilic nanoparticles for drug delivery
#555Compositions for and methods of treating and preventing targeting tumor associated carbohydrate antigens
#556COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#557Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
#558Treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents
#559Use of inhibitors of bruton's tyrosine kinase (Btk)
#560COMBINATION OF A IMIDAZOPYRIDAZINE DERIVATIVE AND A MITOTIC AGENT FOR THE TREATMENT OF CANCER
#561MASITINIB FOR TREATING GASTRIC CANCER
#562Supression of IgE production by compounds derived from traditional chinese medicine
#563Method of treating cancer
#564Combination methods for treating cancers
#565PSMA binding ligand-linker conjugates and methods for using
#566COMBINATION CANCER THERAPY WITH C-MET INHIBITORS AND SYNTHETIC OLIGONUCLEOTIDES
#567Vaporized medicants and methods of use
#568Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
#569Molecular and Herbal Combinations for Treating Psoriasis
#570ITE for cancer intervention and eradication
#571Compositions and methods for enhancing brain function
#572MASITINIB FOR TREATING HEPATIC CANCER
#573Compositions for delivery of drug combinations
#574ASSAYS, METHODS AND KITS FOR ANALYZING SENSITIVITY AND RESISTANCE TO ANTI-CANCER DRUGS, PREDICTING A CANCER PATIENT'S PROGNOSIS, AND PERSONALIZED TREATMENT STRATEGIES
#575Liposomes useful for drug delivery
#576Liposomes useful for drug delivery
#577Antisense compounds and uses thereof
#578Pharmaceutical composition for treating a microbial infection
#579Pre-spray emulsions and powders containing non-polar compounds
#580HUMAN DOSING OF PHOSPHATASE INHIBITOR
#581Anti-DR5 antibodies, polynucleotides and methods
#582PSMA binding ligand-linker conjugates and methods for using
#583Indoline alkaloid compounds
#584Minimally toxic prodrugs
#585Syk inhibitors
#586Molecular and Herbal Combinations with Methotrexate for Treating Diseases and Inflammatory Ailments
#587LONG CIRCULATING NANOPARTICLES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS
#588Oligonucleotides for modulating gene expression and uses thereof
#589Aminoquinazoline derivatives and their salts and methods of use thereof
#590Compositions and methods for drug-sensitization or inhibition of a cancer cell
#591Liposomes useful for drug delivery
#592Controlled drug release liposome composition
#5934-CYANO-N-(2-(4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)-6-(2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-YL)PYRIDIN-3-YL)-1H-IMIDAZOLE-2-CARBOXAMIDE FOR THE TREATMENT OF HODGKIN'S LYMPHOMA
#594COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXITY (ADCC)
#595Oral antiseptic composition useful for treating oral mucositis
#596Block copolymers for stable micelles
#597Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
#598FSH receptor antagonists
#599Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity
#600Potentiation of anticancer agents